By Rishika Sadam March 31 (Reuters) - Novo Nordisk has again cut the prices of its blockbuster diabetes and weight-loss drugs ...

Novo cuts Ozempic, Wegovy prices as generics hit India market. Semaglutide patent expiry sparks price war in India diabetes ...

Novo Nordisk on Tuesday cut the prices of its diabetes and weight-loss drugs Ozempic and Wegovy by as much as 36% and 48% in ...

One of the world’s leading healthcare names, Novo Nordisk (NYSE:NVO) cut prices on Wegovy and Ozempic by up to 48% in India ...

The Danish drugmaker said it will cut the price of the starting dose of Ozempic by 36 percent and that of Wegovy by 48 ...

The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the green light this ...

Novo Nordisk India has cut the prices of its diabetes and weight loss medicine brands Ozempic and Wegovy (GLP-1 receptor ...

Sun Pharma has launched Sematrinity, targeting diabetes, in two formulations priced between ₹3,000 and ₹5,200 per month, ...

Check out the latest Novo Nordisk A/s (NVO) stock quote and chart. View real-time stock prices & the company’s financial overview to help with your trading & investment.

Novo Nordisk on Tuesday announced plans to cut the list price of its popular diabetes and weight-loss drugs Ozempic and Wegovy by as much as 50% in the U.S. next year. The Danish drugmaker indicated ...